# Corimmun

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/corimmun

- Industry: Biotechnology
- Headquarters: Germany
- Website: www.corimmun.com
- Total disclosed funding: $7.9M
- Latest round: Series A (Sep 22, 2008)
- Investors on record: 5

## About

Corimmun GmbH is a biotechnology company, develops therapeutics for the treatment of congestive heart failure and atherosclerosis.

## Funding rounds

- Series A, Sep 22, 2008, $7M — BioM, KfW Banking Group, High-Tech Gruenderfonds, MIG Capital, Bayern Kapital
- Seed, Jan 15, 2007, $0.9M — BioM, High-Tech Gruenderfonds, Bayern Kapital

## Investors

- BioM (https://capitalatlas.ai/funds/biom) — Seed, Series A
- High-Tech Gruenderfonds (https://capitalatlas.ai/funds/high-tech-gruenderfonds) — Seed, Series A
- Bayern Kapital (https://capitalatlas.ai/funds/bayern-kapital) — Seed, Series A
- KfW Banking Group — Series A
- MIG Capital (https://capitalatlas.ai/funds/mig-capital) — Series A